Health
Brisbane biotech company trials drug on US COVID-19 patients in bid to find ‘new way to prevent people dying’ of virus – ABC News
A Brisbane biotech company creates an anti-inflammatory drug which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States…
A Brisbane biotech company, led by award-winning immunologist Ian Frazer, has created an anti-inflammatory drug, which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States.
Key points:
- The drug is being trailed on 300 people in the US, with results expected in about six months
- If successful, drug IC14 could become part of routine care to treat COVID-19 patients with severe infection
- Professor Ian Frazer says the drug could provide a new way to treat people…
Continue Reading
-
General15 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business23 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business22 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General22 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips